NAD+: A key metabolic regulator with great therapeutic potential

G. Sultani, A. F. Samsudeen, B. Osborne, Nigel Turner

Publikation: Bidrag til tidsskriftReviewpeer review

43 Citationer (Scopus)
5 Downloads (Pure)

Abstract

Nicotinamide adenine dinucleotide (NAD+) is a ubiquitous metabolite that serves an essential role in the catabolism of nutrients. Recently, there has been a surge of interest in NAD+ biology, with the recognition that NAD+ influences many biological processes beyond metabolism, including transcription, signalling and cell survival. There are a multitude of pathways involved in the synthesis and breakdown of NAD+, and alterations in NAD+ homeostasis have emerged as a common feature of a range of disease states. Here, we provide an overview of NAD+ metabolism and summarise progress on the development of NAD+-related therapeutics.

OriginalsprogEngelsk
Artikelnummere12508
TidsskriftJournal of Neuroendocrinology
Vol/bind29
Udgave nummer10
ISSN0953-8194
DOI
StatusUdgivet - 2017
Udgivet eksterntJa

Bibliografisk note

Publisher Copyright:
© 2017 British Society for Neuroendocrinology

Citationsformater